Design Pharmaceuticals

Design Pharmaceuticals Utilizes Nature's Drug-Like Molecular Chemistry to Develop Breakthrough Therapies. The company’s approach aims to redesign the small-molecule-based drug discovery and development process by accessing these undiscovered molecules using engineering-inspired biotechnology, saving time and cost while accelerating the drug discovery process. The platform is based on ultra-high-throughput technology, enabling bioprospecting and testing of drug-like molecules from nature across hundreds of GPCR targets simultaneously at unprecedented speed and scale. Design Pharmaceuticals’ cell-free biosynthesis eliminates the inherent limitations of traditional chemistry or platforms based on living production strains. The company’s business model focuses on building a growing portfolio of co-development and licensing agreements with pharmaceutical partners.